Functional role of acetylcholine and the expression of cholinergic receptors and components in osteoblasts

FEBS Letters

Volumn 584, Issue 4, 2010, Pages 817-824

  Sato, Tsuyoshi ^a   Abe, Takahiro ^a   Chida, Dai ^b   Nakamoto, Norimichi ^a   Hori, Naoko ^a   Kokabu, Shoichiro ^a   Sakata, Yasuaki ^a   Tomaru, Yasuhisa ^a   Iwata, Takanori ^c   Usui, Michihiko ^d   Aiko, Katsuya ^e   Yoda, Tetsuya ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e GUNMA PREFECTURAL CANCER CENTER   (Japan)

Author keywords

Acetylcholine; Cholinergic component; Cholinergic receptor; Differentiation; Osteoblast; Proliferation

Indexed keywords

ACETYLCHOLINE; ALKALINE PHOSPHATASE; MESSENGER RNA; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ARTICLE; CELL COMPOSITION; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN QUATERNARY STRUCTURE; RNA ANALYSIS; UPREGULATION;

3T3 CELLS; ACETYLCHOLINE; ACETYLCHOLINESTERASE; ALKALINE PHOSPHATASE; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC AGENTS; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MICE; OSTEOBLASTS; RECEPTORS, CHOLINERGIC; RECEPTORS, MUSCARINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYMPORTERS; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 77649270086     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.01.001     Document Type: Article

References (36)

1. Lerner U.H. Neuropeptidergic regulation of bone resorption and bone formation. J. Musculoskelet. Neuronal. Interact. 2002, 2:440-447.
2. Patel M.S., Elefteriou F. The new field of neuroskeletal biology. Calcif. Tissue Int. 2007, 80:337-347.
3. Takeda S., Karsenty G. Molecular bases of the sympathetic regulation of bone mass. Bone 2008, 42:837-840.
4. Wessler I., Kirkpatrick C.J., Racké K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol. Ther. 1998, 77:59-79.
5. Tacey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 2007, 117:289-296.
6. Fujii T., Takada-Takatori Y., Kawashima K. Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. J. Pharmacol. Sci. 2008, 106:186-192.
7. Song P., Sekhon H.S., Jia Y., Keller J.A., Blusztajn J.K., Mark G.P., Spindel E.R. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res. 2003, 63:214-221.
8. Proskocil B.J., Sekhon H.S., Jia Y., Savchenko V., Blakely R.D., Lindstrom J., Spindel E.R. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 2004, 145:2498-2506.
9. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
10. Wessler I., Kilbinger H., Bittinger F., Kirkpatrick C.J. The biological role of non-neuronal acetylcholine in plants and humans. Jpn. J. Pharmacol. 2001, 85:2-10.
11. Paraoanu L.E., Steinert G., Koehler A., Wessler I., Layer P.G. Expression and possible functions of the cholinergic system in a murine embryonic stem cell line. Life Sci. 2007, 80:2375-2379.
12. Kummer W., Lips K.S., Pfeil U. The epithelial cholinergic system of the airways. Histochem. Cell Biol. 2008, 130:219-234.
13. Hohmann E.L., Elde R.P., Rysavy J.A., Einzig S., Gebhard R.L. Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science 1986, 232:868-871.
14. Hill E.L., Elde R.P. Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat. Cell Tissue Res. 1991, 264:469-480.
15. Francis N.J., Asmus S.E., Landis S.C. CNTF and LIF are not required for the target-directed acquisition of cholinergic and peptidergic properties by sympathetic neurons in vivo. Dev. Biol. 1997, 182:76-87.
16. Asmus S.E., Parsons S., Landis S.C. Developmental changes in the transmitter properties of sympathetic neurons that innervate the periosteum. J. Neurosci. 2000, 20:1495-1504.
17. Asmus S.E., Tian H., Landis S.C. Induction of cholinergic function in cultured sympathetic neurons by periosteal cells: cellular mechanisms. Dev. Biol. 2001, 235:1-11.
18. Hohmann E.L., Tashjian A.H. Functional receptors for vasoactive intestinal peptide on human osteosarcoma cells. Endocrinology 1984, 114:1321-1327.
19. Togari A., Arai M., Mizutani S., Mizutani S., Koshihara Y., Nagatsu T. Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci. Lett. 1997, 233:125-128.
20. Lundberg P., Boström I., Mukohyama H., Bjurholm A., Smans K., Lerner U.H. Neuro-hormonal control of bone metabolism: vasoactive intestinal peptide stimulates alkaline phosphatase activity and mRNA expression in mouse calvarial osteoblasts as well as calcium accumulation mineralized bone nodules. Regul. Pept. 1999, 85:47-58.
21. Sato T., Koseki T., Yamato K., Saiki K., Konishi K., Yoshikawa M., Ishikawa I., Nishihara T. P53-independent expression of p21(CIP1/WAF1) in plasmacytic cells during G(2) cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 2002, 70:528-534.
22. Abe T., Hikiji H., Shin W.S., Koshikiya N., Shima S., Nakata J., Susami T., Takato T., Toyo-oka T. Targeting of iNOS with antisense DNA plasmid reduces cytokine-induced inhibition of osteoblastic activity. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E614-621.
23. Sato T., Abe T., Nakamoto N., Tomaru Y., Koshikiya N., Nojima J., Kokabu S., Sakata Y., Kobayashi A., Yoda T. Nicotine induces cell proliferation in association with cyclin D1 up-regulation and inhibits cell differentiation in association with p53 regulation in a murine pre-osteoblastic cell line. Biochem. Biophys. Res. Commun. 2008, 377:126-130.
24. Nilbratt M., Friberg L., Mousavi M., Marutle A., Nordberg A. Retinoic acid and nerve growth factor induce differential regulation of nicotinic acetylcholine receptor subunit expression in SN56 cells. J. Neurosci. Res. 2007, 85:504-514.
25. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 1996, 16:1077-1085.
26. Ortells M.O., Lunt G.G. Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci. 1995, 18:121-127.
27. Walker L.M., Preston M.R., Magnay J.L., Thomas P.B., El Haj A.J. Nicotinic regulation of c-fos and osteopontin expression in human-derived osteoblast-like cells and human trabecular bone organ culture. Bone 2001, 28:603-608.
28. Katono T., Kawato T., Tanabe N., Suzuki N., Yamanaka K., Oka H., Motohashi M., Maeno M. Nicotine treatment induces expression of matrix metalloproteinases in human osteoblastic Saos-2 cells. Acta. Biochim. Biophys. Sin. (Shanghai) 2006, 38:874-882.
29. Metzen J., Bittinger F., Kirkpatrick C.J., Kilbinger H., Wessler I. Proliferative effect of acetylcholine on rat trachea epithelial cells is mediated by nicotinic receptors and muscarinic receptors of the M1-subtype. Life Sci. 2003, 72:2075-2080.
30. Trombino S., Cesario A., Margaritora S., Granone P., Motta G., Falugi C., Russo P. Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res. 2004, 64:135-145.
31. Dasgupta P., Rastogi S., Pillai S., Ordonez-Ercan D., Morris M., Haura E., Chellappan S. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J. Clin. Invest. 2006, 116:2208-2217.
32. Grisaru D., Lev-Lehman E., Shapira M., Chaikin E., Lessing J.B., Eldor A., Eckstein F., Soreq H. Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3' alternative splicing variant of acetylcholinesterase. Mol. Cell. Biol. 1999, 19:788-795.
33. Inkson C.A., Brabbs A.C., Grewal T.S., Skerry T.M., Genever P.G. Characterization of acetylcholinesterase expression and secretion during osteoblast differentiation. Bone 2004, 35:819-827.
34. Pfeil U., Lips K.S., Eberling L., Grau V., Haberberger R.V., Kummer W. Expression of the high-affinity choline transporter, CHT1, in the rat trachea. Am. J. Respir. Cell Mol. Biol. 2003, 28:473-477.
35. de Jonge W.J., van der Zanden E.P., The F.O., Bijlsma M.F., van Westerloo D.J., Bennink R.J., Berthoud H.R., Uematsu S., Akira S., van den Wijngaard R.M., Boeckxstaens G.E. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 2005, 6:844-851.
36. Hall B.K. Selective proliferation and accumulation of chondroprogenitor cells as the mode of action of biomechanical factors during secondary chondrogenesis. Teratology 1979, 20:81-91.